What are the common locations of Ewing sarcoma in pediatric and young adult patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ewing Sarcoma Locations

The most common primary sites of Ewing sarcoma are the pelvic bones, femur, and bones of the chest wall, with approximately 50% occurring in the extremities and 20% in the pelvis. 1

Primary Skeletal Locations

Most Common Sites

  • Pelvic bones represent one of the three most frequent primary sites 1
  • Femur is the second most common location 1
  • Chest wall bones (ribs and scapula) constitute the third major site 1
  • Any bone may be affected, though the above sites predominate 1

Distribution Pattern

  • 50% of patients have extremity tumors 1
  • 20% have pelvic tumors 1
  • The remaining 30% occur in axial skeleton including spine, chest wall, and other locations 1

Location Within Long Bones

  • When arising in long bones, the diaphysis (shaft) is the most frequently affected site 1
  • Metadiaphyseal locations are also common 2, 3
  • This contrasts with osteosarcoma, which typically affects the metaphyseal region 4

Extraosseous Presentations

  • Approximately 20% of cases emerge from extraosseous (soft tissue) locations 1
  • Extraosseous sites include paravertebral regions, chest wall soft tissues, and other locations 3

Atypical Locations

While less common, Ewing sarcoma can occur in atypical sites including:

  • Metatarsal bones 3
  • Scapula 3
  • Paranasal sinuses 3
  • Intracranial soft tissue 3
  • Spine and sacrum (associated with significantly worse prognosis) 1

Clinical Implications of Location

Prognostic Significance

  • Distal/peripheral sites indicate favorable prognosis 1
  • Pelvic localization is an adverse prognostic factor 1
  • Spine and sacrum locations are associated with significantly worse outcomes compared to other primary sites 1
  • Axial skeleton involvement generally portends poorer prognosis than extremity disease 5

Age and Demographics

  • Ewing sarcoma occurs predominantly in adolescents and young adults (AYAs) with a median age of 14 years 1
  • 90% of patients are under 20 years of age 1
  • The incidence is approximately 1 case per 1.5 million 1

Critical Diagnostic Considerations

Imaging Characteristics by Location

  • Bone appears mottled on imaging regardless of location 1, 2
  • Classic "onion skin" periosteal reaction is characteristic 1, 2
  • Large soft tissue component typically dominates the presentation 1

Important Pitfall

Any patient with radiological findings suggesting Ewing sarcoma must be referred immediately to a specialized bone sarcoma center before biopsy to prevent tissue plane contamination and optimize limb-salvage outcomes 4, 6. The radiosensitive nature of the disease and tendency to arise in the axial skeleton make local treatment particularly challenging 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Radiographic Differentiation of Osteosarcoma from Ewing Sarcoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnosis and Management of Pediatric Thigh Mass Suspicious for Ewing Sarcoma or Osteosarcoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Differentiating Osteosarcoma from Ewing Sarcoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.